| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.042 | 0.6 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |